Hartland & Co »

Neumora Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $14k 8.5k 1.70

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Neumora Therapeutics

Siren
BlackRock
Softbank Group Corp
Tudor Investment Corporation
Vanguard Capital Management
MIC Capital Management UK
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Geode Capital Management
ICONIQ Capital
Two Sigma Investments
OrbiMed Advisors
Lunate Capital
Boxer Capital Management
Johnson & Johnson

View all funds holding Neumora Therapeutics